Search

Search Constraints

You searched for: Author/Creator Borroni, Edilio

Search Results

1. [18F]RO‐948 Tau PET Retention and Correlation with Fluid Tau Biomarkers in the Early AD Continuum. (20th December 2022)

2. [IC‐P‐188]: ON EVALUATION OF TAU ACCUMULATIONS IN LONGITUDINAL STUDIES OF ALZHEIMER's DISEASE (AD): IMPLICATIONS FROM A PET STUDY WITH [18F]RO6958948. (1st July 2017)

3. A Comparative Study of in vitro Assays for Predicting the Nonspecific Binding of PET Imaging Agents in vivo. (13th December 2019)

4. Ability of tau‐PET, phospho‐tau217, NfL and cortical thickness to predict short‐term cognitive decline in early symptomatic Alzheimer's disease. (December 2021)

5. Ability of tau‐PET, phospho‐tau217, NfL and cortical thickness to predict short‐term cognitive decline in early symptomatic Alzheimer's disease. Issue 4 (1st February 2022)

6. Biomarker driven enrichment strategies for tau pathology in AD clinical trials. (31st December 2021)

7. Comparison of group‐level and individualized ROIs for predicting change in longitudinal tau‐PET in preclinical and prodromal AD. (20th December 2022)

8. Cover Feature: A Comparative Study of in vitro Assays for Predicting the Nonspecific Binding of PET Imaging Agents in vivo (ChemMedChem 7/2020). (1st April 2020)

9. DT‐01‐04: DIAGNOSTIC PERFORMANCE OF [18F]RO948 PET IN THE SEPARATION OF ALZHEIMER'S DISEASE FROM OTHER NEURODEGENERATIVE DISORDERS: FINDINGS FROM THE BIOFINDER‐2 STUDY. (1st July 2019)

10. Increased basal ganglia binding of 18F‐AV‐1451 in patients with progressive supranuclear palsy. Issue 1 (6th October 2016)